Cathepsin D in cancer metastasis: A protease and a ligand

APMIS

Volumn 107, Issue 1, 1999, Pages 86-95

  Rochefort, Henri ^a,b   Liaudet Coopman, Emmanuelle ^a  

^a UNIV MONTPELLIER   (France)

^b INSERM   (France)

Author keywords

Breast cancer; Cathepsin D; Extracellular matrix; FGF2; Growth factor; Growth inhibitor; Metastasis; Phagocytosis; Proteases

Indexed keywords

CATHEPSIN D; COMPLEMENTARY DNA; PROTEINASE;

BASEMENT MEMBRANE; CANCER GROWTH; CANCER INVASION; CELL PROLIFERATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GROWTH STIMULATION; HUMAN; METASTASIS POTENTIAL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW;

EID: 0033043062     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1999.tb01530.x     Document Type: Review

References (78)

1. 1. Barrett AJ. Cathepsin D: Purification of isoenzymes from human and chicken liver. Biochem J 1970;117: 601-7.
2. 2. Rochefort H, Cavaillès V, Augereau P, Capony F, Maudelonde T, Touitou I, et al. Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancer. J Steroid Biochem 1989;34:177-82.
3. 3. Cavaillès V, Augereau P, Rochefort H. Cathepsin D gene is controlled by a mixed promoter and estrogens stimulate only TATA dependent transcription in breast cancer cells. Proc Natl Acad Sci USA 1993;90:203-7.
4. 4. Rio M-C, Bellocq JP, Gairard B, et al. Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERB2. Proc Natl Acad Sci USA 1987;84:9243-7.
5. 5. Thorpe SM, Rochefort H, Garcia M, Freiss G, Christensen IJ, Khalaf S, et al. Association between high concentrations of Mr 52,000 cathepsin-D and poor prognosis in primary human breast cancer. Cancer Res 1989;49:6008-14.
6. 6. Rochefort H: Cathepsin D in breast cancer: a tissue marker associated with metastasis. Eur J Cancer 1992;28A:1780-3.
7. 7. Cardiff RD: Cathepsin D and breast cancer: Useful? Hum Pathol 1994;25:847-8.
8. 8. Roger P, Montcourrier P, Maudelonde T, Brouillet JP, Pages A, Laffargue F, et al. Cathepsin D immunostaining in paraffin-embedded breast cancer cells and macrophages. Correlation with cytosolic assay. Human Path 1994;25:863-71.
9. 9. Ferrandina G, Scambia G, Bardelli F, Panici B, Mancuso S, Messori A. Relationship between cathepsin-D content and disease-free survival in node-negative breast cancer patients: a meta-analysis. Br J Cancer 1997;76: 661-6.
10. 10. Foekens JA, Look MP, Bolt-de Vries J, Meijer-van Gelder M, van Putten WLJ, Klijn JGM. Cathepsin D in primary breast cancer: prognostic evaluation involving 2810 patients. Br J Cancer 1999;79:300-7.
11. 11. Brouillet JP, Hanslick B, Maudelonde T, Pivat MT, Grenier J, Blanc F, et al. Increased plasma cathepsin D concentration in hepatic carcinoma and cirrhosis but not in breast cancer. Clin Biochem 1991;24:491-6.
12. 12. Brouillet JP, Dufour F, Lemamy G, Garcia M, Schlup N, Grenier J, et al. Increased cathepsin D level in serum of patients with metastatic breast carcinoma detected with a specific pro-cathepsin D immunoassay. Cancer 1997;79:2132-6.
13. 13. Jarosz DE, Hamer PJ, Tenney DY, Zabrecky JR. Elevated levels of pro-cathepsin D in the plasma of breast cancer patients. Int J Oncol 1995;6:859-65.
14. 14. Westley B, May FEB, Brown AMC, Krust A, Chambon P, Lippman MD, et al. Effects of antiestrogens on the estrogen-regulated pS2 RNA, and the 52-K and 160-kilodalton proteins in MCF7 cells and two tamoxifen resistant sublines. J Biol Chem 1984;259:10030-5.
15. 15. Diment S, Martin KJ, Stahl PD. Cleavage of parathyroid hormone in macrophage endosomes illustrates a novel pathway for intracellular processing of proteins. J Biol Chem 1989;264:13403-6.
16. 16. Saftig P, Hetman M, Schmahl W, Weber K, Heine L, Mossmann H, et al. Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells. EMBO J 1995;14:3599-608.
17. 17. Redecker B, Heckendorf B, Grosch HW, Mersmann G, Hasilik A. Molecular organization of the human cathepsin D gene. DNA Cell Biol 1991;10:423-31.
18. 18. Augereau P, Garcia M, Mattei MG, Cavaillès V, Depadova F, Derocq D, et al. Cloning and sequencing of the 52K cathepsin D cDNA of MCF7 breast cancer cells and mapping on chromosome II. Mol Endo 1988; 2:186-92.
19. 19. Davies DR. The structure and function of the aspartic proteinases. Annu Rev Biophys Chem 1990;19:189-215.
20. 20. Briozzo P, Morisset M, Capony F, Rougeot C, Rochefort H. In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells. Cancer Res 1988;48:3688-92.
21. 21. Samarel AM, Ferguson AG, Decker RS, Lesch M. Effects of cysteine protease inhibitors on rabbit cathepsin D maturation. Am J Physiol 1989;257:C1069-79.
22. 22. Yonezawa S, Takahashi T, Wang X, Wong RNS, Hartsuck JA, Tang J. Structures at the proteolytic processing region of cathepsin D. J Biol Chem. 1988;263:16504-11.
23. 23. Pearl LH, Taylor WR. A structural model for the retroviral proteases. Nature 1987;329:351-3.
24. 24. Metcalf P, Fusek M. Two crystal structures for cathepsin D: the lysosomal targeting signal and active site. EMBO J 1993;12:1293-302.
25. 25. Richo GR, Conner GE. Structural requirements of pro-cathepsin D activation and maturation. J Biol Chem 1994;269:14806-12.
26. 26. Umezawa H, Aoyagi T, Morishima H, Matsuzaki M, Hamada M, Takeuchi T. Pepstarin, a new pepsin inhibitor produced by actinomycetes. J Antibiot 1970;23:259-62.
27. 27. Baldwin ET, Bhat TN, Gulnik S, Hosur MV, Sowder II RC, Cachau RE, et al. Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design. Proc Natl Acad Sci USA 1993;90:6796-800.
28. 28. Kick EK, Roe DC, Skillman AG, Liu G, Ewing TJ, Sun Y, et al. Structure-based design and combinatorial chemistry yield low nanomolar inhibitors of cathepsin D. Chem Biol (England) 1997;4:297-307.
29. 29. Wittlin S, Rösel J, Stover DR. One-step purification of cathepsin D by affinity chromatography using immobilized propeptide sequences. Eur J Biochem 1998;252: 530-6.
30. 30. Conner GE. The role of the cathepsin D propeptide in sorting to the lysosome. J Biol Chem 1992;267:21738-45.
31. 31. Fortenberry SC, Chirgwin JM. The propeptide is nonessential for the expression of human cathepsin D. J Biol Chem 1995;270:9778-82.
32. 32. Beyer BM, Dunn BM. Self-activation of recombinant human lysosomal procathepsin D at a newly engineered cleavage junction, "short" pseudocathepsin D. J Biol Chem 1996;271:15590-6.
33. 33. Faust PL, Kornfeld S, Chirgwin JM. Cloning and sequence analysis of cDNA for human cathepsin D. Proc Natl Acad Sci USA 1985;82:4910-4.
34. 34. Westley BR, May FEB. Oestrogen regulates cathepsin D mRNA levels in oestrogen responsive human breast cancer cells. Nucl Acids Res 1987;15:3773-86.
35. 35. Touitou I, Capony F, Brouillet JP, Rochefort H. Mis-sense polymorphism (C/T224) in the human cathepsin D pro-fragment determined by polymerase chain reaction-single strand conformational polymorphism analysis and possible consequences in cancer cells. Eur J Cancer 1994;30:390-4.
36. 36. Fortenberry SC, Schorey JS, Chirgwin JM. Role of glycosylation in the expression of human procathepsin D. J Cell Sci 1995;108:2001-6.
37. 37. Zhu Y, Conner GE. Intermolecular association of lysosomal protein precursors during biosynthesis. J Biol Chem 1994;269:3846-51.
38. 38. Capony F, Braulke T, Rougeot C, Roux S, Montcourrier P, Rochefort H. Specific mannose-6-phosphate receptor-independent sorting of pro-cathepsin D in breast cancer cells. Exp Cell Res 1994;215:154-163.
39. 39. Capony F, Morisset M, Barrett AJ, Capony JP, Broquet P, Vignon F, et al. Phosphorylation, glycosylation and proteolytic activity of the 52K estrogen-induced protein secreted by MCF7 cells. J Cell Biol 1987;104:253-62.
40. 40. Capony F, Rougeot C, Montcourrier P, Cavaillès V, Salazar G, Rochefort H. Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells. Cancer Res 1989;49:3904-9.
41. 41. Garcia D, Derocq D, Pujol P, Rochefort H. Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency. Oncogene 1990;5:1809-14.
42. 42 Liaudet E, Garcia M, Rochefort H. Cathepsin D maturation and its stimulatory effect on metastasis are prevented by addition of KDEL retention signal. Oncogene 1994;9:1145-54.
43. th Annual Meeting of the American Association for Cancer Research, March 28-April 1, 1998, New Orleans (LA, USA).
44. 44. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991;64:327-36.
45. 45. Erickson AH. Biosynthesis of lysosomal endopeptidases. J Cell Biochem 1989;40:31-41.
46. 46. Diment S, Leech MS, Stahl PD: Cathepsin D is membrane-associated in macrophage endosomes. J Biol Chem 1988;263:6901-7.
47. 47. Rijnboutt S, Aerts HMFG, Geuze HJ, Tager JM, Strous GJ. Identification of subcellular compartments involved in biosynthelic processing of cathepsin D. J Biol Chem 1991;266:4862-8.
48. 48. Montcourrier P, Mangeat P, Salazar G, Morisset M, Sahuquet A, Rochefort H. Cathepsin D in breast cancer cells can digest extracellular matrix in large acidic vesicles. Cancer Res 1990;50:6045-54.
49. 49. Montcourrier P, Mangeat P, Valembois C, Salazar G, Sahuquet A, Duperray C, et al. Characterization of very acidic phagosomes in breast cancer cells and their association with invasion. J Cell Science 1994;107:2381-91.
50. 50. Van Peteghem MC, Mareel MM, De Bruyne GK. Phagocytic capacity of invasive malignant cells in the three-dimensional culture. Virchows Arch B 1980;55: 167-93.
51. 51. Coopman PJ, Do MTH, Thompson EW, Mueller SC. Phagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity. Clin Cancer Res 1998;4:507-15.
52. 52. Coopman PJ, Thomas DM, Gehlsen KR, Mueller SC. Integrin alpha 3 beta 1 participates in the phagocytosis of extracellular matrix molecules by human breast cancer cells. Mol Biol Cell 1996;7:1789-804.
53. 53. Rochefort H. Oestrogens, proteases and breast cancers. From cell lines to clinical applications. Eur J Cancer 1994;30A:1583-6.
54. 54. Liaudet E, Derocq D, Rochefort H, Garcia M: Transfected cathepsin D stimulates high density cancer cell growth by inactivating secreted growth inhibitors. Cell Growth Diff 1995;6:1045-52.
55. 55. Griffiths JR. Are cancer cells acidic? Br J Cancer 1991;64:425-7.
56. 56. Silver IA, Murrills RJ, Etherington DJ. Microelectrode studies on the acid microenvironment beneath adherent macrophages on osteoclasts. Exp Cell Res 1988;175: 266-76.
57. 57. Montcourrier P, Silver IA, Farnoud R, Bird I, Rochefort H. Breast cancer cells have a high capacity to acidify extracellular milieu by a dual mechanism. Clin Exp Metast 1997;15:382-92.
58. 58. Briozzo P, Badet J, Capony F, Pieri I, Montcourrier P, Barritault D, et al. MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D. Exp Cell Res 1991;194:252-9.
59. 59. Rifkin DB. Cross-talk among proteases and matrix in the control of growth factor action. Fibrinolysis & Proteolysis 1997;11:3-9.
60. 60. Van der Stappen JWJ, Williams AC, Maciewicz RA, Paraskeva C. Activation of cathepsin B, secreted by a colorectal cancer cell line requires low pH and is mediated by cathepsin D. Int J Cancer 1996;67:547-54.
61. 61. Kobayashi H, Schmitt M, Goretzki L, Chucholowski N, Calvete J, Kramer M, et al. Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (pro-uPA). J Biol Chem 1990;266:5147-52.
62. 62. Lenarcic B, Kos J, Dolens I, Locovnik P, Krizaj I, Turk V. Cathepsin D inactivates cysteine proteinase inhibitors cystatins. Biochem Biophys Res Commun 1988;154: 765-72.
63. 63. Deussing J, Roth W, Saftig P, Peters C, Ploegh HL, Villadangos JA. Cathepsins and D are dispensable for major histocompatibility complex class II-mediated antigen presentation. Proc Natl Acad Sci USA 1998;95:4516-21.
64. 64. Gottesman MM. The role of proteases in cancer. In: Seminars in Cancer Biology. London: Saunders Scientific Publications; 1990. Vol. 1.
65. 65. Von Figura K, Hasilik A. Lysosomal enzymes and their receptors. Ann Rev Biochem 1986;55:167-93.
66. 66. Ludwig T, Munier-Lehmann H, Bauer U, Hollinshead M, Ovitt C, Lobel P, et al. Differential sorting of lysosomal enzymes in mannose-6-phosphate receptor-deficient fibroblasts. EMBO J 1994;13:3430-7.
67. 67. Nykjaer A, Christensen EI, Vorum H, Hager H, Petersen CM, Roigaard H, et al. Mannose-6-phosphate/ insulin-like growth factor-II receptor targets the urokinase receptor to lysosomes via a novel binding interaction. J Cell Biol 1998;141:815-28.
68. 68. Mathieu M, Vignon F, Capony F, Rochefort H: Estradiol downregulates the mannose-6-phosphate/IGFII receptor gene and induces cathepsin D in breast cancer cells: A receptor saturation mechanism to increase the secretion of lysosomal pro-enzymes. Mol Endocrinol 1991;5:815-22.
69. 69. De Souza AT, Hankins GR, Washington MK, Orton TC, Jirtle JL. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nature Genet 1995;12:2003-9.
70. 70. Hankins GR, De Souza AT, Bentley RC, Patel MR, Marks JR, Iglehart JD, Jirtle JL. M6P/IGFII receptor: a candidate breast tumor suppressor gene. Oncogene 1996;12:2003-9.
71. 71. Galtier-Dereure F, Capony F, Maudelonde T, Rochefort H. Estradiol stimulates cell growth and secretion of pro-cathepsin D and a 120-kilodalton protein in the human ovarian cancer cell line BG-1. J Clin Endocrinol Metab 1992;75:1497-502.
72. 72. Zhu Y, Conner GE. Intermolecular association of lysosomal protein precursors during biosynthesis. J Biol Chem 1994;269:3846-51.
73. 73. Glickman JN, Kornfeld S. Mannose-6-phosphate-independent targeting of lysosomal enzymes in I-cell disease B lymphoblasts. J Cell Biol 1993;123:99-108.
74. 74. Laurent V, Farnoud MR, Lucas A, Rougeot C, Garcia M, Rochefort H. Endocytosis of pro-cathepsin D into breast cancer cells is mostly independent of mannose-6-phosphate receptors. J. Cell Science 1998;111:2539-49.
75. 75. Fusek M, Vetvicka V. Mitogenic function of human pro-cathepsin D: the role of the propeptide. Biochem J 1994;303:775-80.
76. 76. Vetvicka V, Vetvickova J, Hilgert I, Voburka Z, Fusek M. Analysis of the interaction of procathepsin D activation peptide with breast cancer cells. Int J Cancer 1997;73:403-9.
77. 77. Vignon F, Capony F, Chambon M, Freiss G, Garcia M, Rochefort H. Autocrine growth stimulation of the MCF7 breast cancer cells by the estrogen-regulated 52k protein. Endocrinology 1986;118:1537-45.
78. 78. Stewart AJ, Piggott NH, May FEB, Westley BR. Mitogenic activity of procathepsin D purified for conditioned medium of breast cancer cells by affinity chromatography on pepstatinyl agarose. Int J Cancer 1994;57:715-18.